Fuchs (XTRA:FPE3) Raised 2026 Guidance, Is The Stock Now Fully Valued?
Fuchs (XTRA:FPE3) moved into focus after management raised earnings guidance for 2026, now targeting EBIT of around €500 million on sales of roughly €4.1 billion.
Short term trading has been choppy, with the share price slipping 0.6% on the day and 3.2% over the past week, yet Fuchs now trades at €44.68 after a 16.8% year to date share price return and a 19.6% one year total shareholder return. This suggests momentum has been building rather than fading.
Scan for other materials stocks that show similar earnings momentum and pricing trends using our hand picked 195 high quality undervalued stocks, which pairs solid cash flows with balance sheet strength.
Fuchs has re-rated after the guidance lift, yet the share price still sits below both analyst targets and intrinsic value estimates. Where does fair value really land inside that spread?
Most Popular Narrative: 6% Undervalued
On the widely followed narrative view, Fuchs screens as slightly undervalued, with a fair value of €47.56 against the latest €44.68 close. This leaves a modest gap for investors to interpret.
The key requirement is that Fuchs delivers on the FUCHS100 focus areas and Transform2Grow efficiency plans while managing raw material and regional disruptions without eroding its roughly 35% gross margin profile.
The current valuation suggests the Fuchs share price already reflects a fairly valued, optimistic view that the company will achieve its stated 2026 guidance and longer term FUCHS100 EBIT and growth ambitions without major lasting setbacks.
See why 8 investors see Fuchs as 6% undervalued.
Result: Fair Value of €47.56 (UNDERVALUED)
Still, prolonged macro weakness in Europe and the Americas or sustained raw material and wage cost pressure could squeeze Fuchs margins and unsettle that fair value story.
Find out about the key risks to this Fuchs narrative.
Another View: Fuchs On Earnings Multiples
Looking at Fuchs through its P/E ratio instead of fair value models provides a different signal. The stock trades on 17.2x earnings, above the European Chemicals average of 16.3x and also above its own fair ratio of 16.2x. That gap points to some valuation risk if sentiment cools.
For investors comparing earnings based pricing to cash flow based estimates, it helps to see how the numbers are built up in detail, so See what the numbers say about this price — find out in our valuation breakdown..
Next Steps
Sentiment looks cautiously optimistic around Fuchs, so treat this as your cue to review the numbers yourself and stress test the narrative before it moves on without you. To see what supporters are focusing on, review the 4 key rewards.
Looking for more investment ideas beyond Fuchs?
Do not stop with one stock. Broaden your watchlist with focused ideas that fit different goals, so you always have options when conditions change.
- Hunt for mispriced quality and scan a curated pool of resilient cash generators using the 195 high quality undervalued stocks.
- Target income resilience and see which companies stack up as potential cash payout anchors through the 224 dividend fortresses.
- Prioritise capital preservation and filter for sturdier balance sheets and fundamentals with the list of solid balance sheet and fundamentals (207 results).
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com